Debate between brand and generic drug companies contues to rage over whether the Waxman-Hatch Act should be overhauled.
Sulbactam-Durlobactam for Bacterial Pneumonia Gets FDA Approval
May 24th 2023The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.
2 Clarke Drive
Cranbury, NJ 08512